--- title: "Labcorp Holdings Inc. (LH.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/LH.US.md" symbol: "LH.US" name: "Labcorp Holdings Inc." industry: "Health Care Services" datetime: "2026-05-20T22:45:42.834Z" locales: - [en](https://longbridge.com/en/quote/LH.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/LH.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/LH.US.md) --- # Labcorp Holdings Inc. (LH.US) ## Company Overview Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. | Item | Detail | |------|--------| | Industry | Health Care Services | | Exchange | US Market | | Website | [www.labcorp.com](https://www.labcorp.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: B > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:16.000Z **Overall: B (0.38)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 5 / 87 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Large - The company has stable operations, allowing for dependable long-term returns. **Multi Score**: B #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 7.34% | | | Net Profit YoY | 28.83% | | | P/B Ratio | 2.38 | | | Dividend Ratio | 1.14% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 20802580000.00 | | | Revenue | 14144200000.00 | | #### Multi Score Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 11.05% | B | | Profit Margin | 6.66% | B | | Gross Margin | 28.66% | C | | Revenue YoY | 7.34% | C | | Net Profit YoY | 28.83% | B | | Total Assets YoY | 8.43% | B | | Net Assets YoY | 5.09% | C | | Cash Flow Margin | 192.62% | B | | OCF YoY | 7.34% | C | | Turnover | 0.77 | B | | Gearing Ratio | 54.18% | C | ```chart-data:radar { "title": "Longbridge Financial Score - Labcorp Holdings Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "7.34%", "rating": "" }, { "name": "Net Profit YoY", "value": "28.83%", "rating": "" }, { "name": "P/B Ratio", "value": "2.38", "rating": "" }, { "name": "Dividend Ratio", "value": "1.14%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "20802580000.00", "rating": "" }, { "name": "Revenue", "value": "14144200000.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "B", "indicators": [ { "name": "ROE", "value": "11.05%", "rating": "B" }, { "name": "Profit Margin", "value": "6.66%", "rating": "B" }, { "name": "Gross Margin", "value": "28.66%", "rating": "C" }, { "name": "Revenue YoY", "value": "7.34%", "rating": "C" }, { "name": "Net Profit YoY", "value": "28.83%", "rating": "B" }, { "name": "Total Assets YoY", "value": "8.43%", "rating": "B" }, { "name": "Net Assets YoY", "value": "5.09%", "rating": "C" }, { "name": "Cash Flow Margin", "value": "192.62%", "rating": "B" }, { "name": "OCF YoY", "value": "7.34%", "rating": "C" }, { "name": "Turnover", "value": "0.77", "rating": "B" }, { "name": "Gearing Ratio", "value": "54.18%", "rating": "C" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 22.10 | 13/87 | 29.96 | 26.56 | 24.84 | | PB | 2.38 | 24/87 | 2.70 | 2.57 | 2.48 | | PS (TTM) | 1.47 | 39/87 | 1.69 | 1.61 | 1.55 | | Dividend Yield | 1.14% | 8/87 | 1.13% | 1.08% | 1.04% | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Cigna (CI.US) | B | C | A | D | B | B | | 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B | | 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B | | 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B | | 05 | Labcorp (LH.US) | B | B | B | C | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-05-18T04:00:00.000Z Total Analysts: **20** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 12 | 60% | | Overweight | 3 | 15% | | Hold | 4 | 20% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 257.42 | | Highest Target | 340.00 | | Lowest Target | 270.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/LH.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/LH.US/norm.md) - [Related News](https://longbridge.com/en/quote/LH.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/LH.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**